Takeda to divest consumer healthcare business to Blackstone for $2.3bn
Japanese pharma giant Takeda Pharmaceutical has agreed to sell its consumer healthcare business to Oscar A-Co KK, a company controlled by funds managed by The Blackstone Group and its affiliates (collectively Blackstone) for JPY 242 billion ($2.3 billion). The business being divested- Takeda Consumer Healthcare Company (TCHC) is focused on the consumer health care market […]